difluoromethylornithine ( dfmo ) , an irreversible inhibitor of ornithine decarboxylase , and human leukocyte interferon ( ifn-alpha ) have synergistic anti-tumor activities in vivo in b 16 melanoma and in vitro against several human cancer cell lines .
C0027651
tumor
C0006826
cancer